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Unfolded protein responseBackground: Protein O-mannosylation is a vital type of glycosylation that is conserved among fungi, animals,
and humans. It is initiated in the endoplasmic reticulum (ER) where the synthesis of the mannosyl donor
substrate and the mannosyltransfer to proteins take place. O-mannosylation defects interfere with cell wall
integrity and ER homeostasis in yeast, and deﬁne a pathomechanism of severe neuromuscular diseases in
humans. Scope of review: On the molecular level, the O-mannosylation pathway and the function of
O-mannosyl glycans have been characterized best in the eukaryotic model yeast Saccharomyces cerevisiae.
In this review we summarize general features of protein O-mannosylation, including biosynthesis of the
mannosyl donor, characteristics of acceptor substrates, and the protein O-mannosyltransferase machinery
in the yeast ER. Further, we discuss the role of O-mannosyl glycans and address the question why protein
O-mannosylation is essential for viability of yeast cells. General signiﬁcance: Understanding of the molecular
mechanisms of protein O-mannosylation in yeast could lead to the development of novel antifungal drugs. In
addition, transfer of the knowledge from yeast to mammals could help to develop diagnostic and therapeutic
approaches in the frame of neuromuscular diseases. This article is part of a Special Issue entitled: Functional
and structural diversity of endoplasmic reticulum.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Glycosylation is the most common and at the same time the most
diverse protein modiﬁcation in eukaryotic cells [1]. Over the years
it appeared that a variety of protein-linked glycan structures play
crucial roles in numerous cellular processes including cell-cell recog-
nition, signal transduction, and ER protein quality control [2–7]. Espe-
cially in the recent past, glycosylation defects in humans have been
identiﬁed as pathomechanism underlying a diverse set of severe con-
genital disorders [8–10], highlighting the impact of protein glycosyl-
ation on growth and development of eukaryotes.
Fungi and animals share three vital types of protein glycosylation
that are initiated in the endoplasmic reticulum (ER): N-glycosylation,
O-mannosylation and glypiation [11,12]. This review will focus on
protein O-mannosylation.
O-mannosyl glycans were ﬁrst identiﬁed in baker's yeast [13]
where they are frequent modiﬁcations of secreted and cell wall; Dol-P, dolichol phosphate;
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l rights reserved.proteins [14]. These short oligomannose chains [15] are attached via
a glycosidic bond in alpha anomeric conﬁguration to the hydroxyl
group of Ser or Thr residues [16]. Mannosyltransfer of the reducing
terminal mannose residue takes place in the ER [17] and is catalyzed
by a conserved family of protein O-mannosyltransferases (PMTs; see
below).
In baker's yeast the initial mannose may be step-wise extended in
the cis and medial Golgi apparatus by α1,2-mannosyltransferases of
the KTR-family to form α1,2-linked mannodi- and mannotriose
[18,19]. Further α1,3-linked mannoses can be added in the medial
and trans Golgi by α1,3-mannosyltransferases of the MNN1-family
[18,20,21] to form linear oligosaccharides that are in the majority of
cases up to ﬁve mannosyl residues long. In addition, mannosyl phos-
phate can be incorporated by the mannosylphosphate transferases
Mnn6 and Mnn4, although for the latter transferase activity has not
been proven directly [22].
In the following article, we will discuss the main aspects of protein
O-mannosylation in the ER with emphasis on PMTs of the eukaryotic
model organism Saccharomyces cerevisiae.2. The mannosyl donor dolichol phosphate-mannose
The biosynthesis of O-mannosyl glycans starts in the ER where
dolichol phosphate ß-D-mannose (Dol-P-Man) is the only mannosyl
donor in all eukaryotes [23,24]. Dolichol is a long-chain polyprenol de-
rivative that in baker's yeast is composed of 14-17 isoprene moieties
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α-saturated isoprene unit. At the cytosolic leaﬂet of the ER membrane
dolichol is phosphorylated by the dolichol kinase Sec59 [26]. Mannose
is then transferred from GDP-α-D-mannose (GDP-Man) to dolichol
phosphate (Dol-P) with inversion of the anomeric conﬁguration at the
C1 atom of the mannosyl residue [16] (Fig. 1). This mannosyltransfer
is catalyzed by GDP-α-D-Man:Dol-P ß-D-mannosyltransferase (EC
2.4.1.83; Dpm1) that belongs to the CAZy glycosyltransferase family 2
(GT2; http://www.cazy.org). Dpm1 was ﬁrst puriﬁed in S. cerevisiae,
allowing cloning of the corresponding gene [27,28]. Recombinant
expression in Escherichia coli demonstrated that Dpm1 is the catalyt-
ic Dol-P-Man synthase [28]. The knockout of DPM1 turned out to be
lethal in baker's yeast, ﬁnally proving that Dol-P-Man is essential for
cell viability reﬂecting its role as mannosyl donor in N-glycosylation,
O-mannosylation and glypiation [29]. Based on homology to the en-
zyme from baker's yeast, DPM homologues from numerous organ-
isms were identiﬁed, which fall into two major subgroups: i)
individual membrane proteins, like S. cerevisiae Dpm1, that have a
single transmembrane helix near the carboxyl-terminus and are
fully functional when heterologously expressed in E. coli or mamma-
lian cells [28,30]; and ii) proteins, like Schizosaccharomyces pombe
and human DPM1, that lack the C-terminal hydrophobic region
[31] and depend on the membrane proteins DPM2 and DPM3 for
full enzymatic activity [32,33]. DPM2 and DPM3 are tethering
DPM1 to the ER membrane, thereby stabilizing DPM1 [33], and
most likely facilitating interactions with its substrate Dol-P. Recent-
ly, a third subgroup has been identiﬁed in the human pathogen Plas-
modium falciparum that lacks DPM2 and DPM3. PfDPM1 bears a
single hydrophobic helix near the N-terminus and is functional in
S. pombe, but not S. cerevisiae or human cells [34]. For a detailedFig. 1. Protein glycosylation in the ER. Dol-P-Man serves as mannosyl donor for the ini-
tial steps of N-glycosylation, O-mannosylation and glypiation. It is synthesized on the
cytosolic face of the ER membrane by Dpm1 catalyzing the mannosyltransfer from
GDP-Man to Dol-P. Dol-P-Man is ﬂipped across the ER membrane and used as
mannosyl donor for the assembly of the core oligosaccharide (1), transfer on Ser/Thr
residues by PMTs (2), and biosynthesis of GPI anchors (3).discussion of Dol-P-Man synthases other than baker's yeast, we
refer to the review by Maeda and Kinoshia [35].
S. cerevisiae Dpm1 is a membrane protein that is facing the cyto-
solic side of the ER membrane [28]. Thereby Dpm1 can interact with
both, the water-soluble mannosyl donor substrate GDP-Man in the
cytosol and the highly hydrophobic mannosyl acceptor Dol-P within
the ER membrane. Up to date, the three-dimensional (3D) crystal
structure of yeast Dpm1 has not been resolved, however, usage of
Dol-P and synthetic Dol-P analogs containing a ﬂuorophore group
provided a 3D structural model of the enzyme with bound
GDP-Man, Dol-P and Mg2+ ions to trace substrate binding and cata-
lytic sites [36,37]. A two-domain structure was predicted with an
N-terminal domain, which is made up of parallel ß-strands, and a
C-terminal domain consisting of antiparallel ß-strands, each ﬂanked
by α-helices on both sides. The model infers that the active site is a
long shallow and wide cleft spanning the two domains of the protein
with the GDP-binding site located in the N-terminal region whereas
mannose and Dol-P binding is restricted to the C-terminal domain.
Interactions of Dpm1 with Dol-P are restricted to a few isoprene
units and the phosphate group at the α-terminus. Further, the
model indicates that the amino acid residues Tyr12, Asp44, Asp97,
and Arg212, which are conserved among DPMs from various organ-
isms, form the active site [37].
The resulting Dol-P-Man is ﬂipped from the cytosolic to the
luminal leaﬂet of the ER membrane (Fig. 1), a process that most likely
depends on a transport facilitator also referred to as ﬂippase [38–40].
Dpm1 itself was proposed to act as ﬂippase [41], but was subse-
quently ruled out as playing a direct role in Dol-P-Man ﬂip-ﬂopping
[42]. Although numerous approaches over the last 30 years have
addressed the translocation of Dol-P-Man [39], and despite the recent
success in reconstituting Dol-P-Man transport into proteoliposomes
containing rat liver ER membrane proteins [43], Dol-P-Man ﬂippases
have not yet been identiﬁed in eukaryotes. Interestingly, based on
NMR and molecular modeling studies on the membrane orientation
of dolichols and their interaction with dolichol recognition se-
quence peptides (also present in Dpm1), Zhou and Troy [44]
constructed the hypothesis that dolichol-induced changes of the
membrane structure may have the potential of forming a mem-
brane channel that could facilitate the movement of hydrophilic
sugar chains across hydrophobic membranes. However it is done,
Dol-P-Man ﬂipping into the ER lumen remains a mystery, both in
mammals and yeast.
3. The PMT family of protein O-mannosyltransferases
In the mid-70s, ribosomal proﬁles of regenerating yeast pro-
toplasts labeled with radioactive Dol-P-Man revealed that in the
presence of cycloheximide protein O-mannosylation was mainly
detected at the polysomal level [45]. Since then it is generally accept-
ed that O-mannosylation is initiated while proteins are translocated
into the ER lumen. More recently, it became obvious that various un-
folded proteins receive O-mannosyl glycans while they are retained
in the ER, showing that O-mannosylation can also occur in the ER
after protein translocation (see below).
In the ER lumen, dolichol phosphate ß-D-mannose: protein
O-mannosyltransferases (PMTs; EC 2.4.1.109) are the key enzymes
that speciﬁcally initiate protein O-mannosylation. These enzymes
catalyze the transfer of a mannosyl residue from Dol-P-ß-D-Man
to Ser and Thr residues of secretory and membrane proteins in
α-D-mannosidic linkage [16] (Fig. 1). As in the case of Dpm1 the
ﬁrst PMT (Pmt1) was puriﬁed from baker's yeast leading to the clon-
ing of the corresponding PMT1 gene [11,46,47]. Based on homology to
Pmt1, a family of protein O-mannosyltransferases comprising at least
six members (Pmt1-Pmt6) was found in S. cerevisiae [48–51]. In the
following years it turned out, that PMTs are conserved throughout
the fungal and animal kingdoms, and are even present in some
Fig. 2. Molecular structure of PMT proteins. (A) Topology model of Pmt1 according to
[71]. The conserved Asp-Glu (DE) motif in loop1 and N-glycosylation sites (Y) are indi-
cated. In loop5, the MIR motifs are colored in orange, blue, and green. (B) Ribbon rep-
resentation of a Pmt4 loop5-MIR domain model, modeled by the SWISS-MODEL server
[135] based on the AtSDF2 structure. A ß-trefoil fold is made up of the three MIR motifs
(color coded as in (A)) giving rise to a pseudo 3-fold symmetry. The view on the right
is rotated by 180° along a vertical axis with respect to the view on the left.
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(http://www.cazy.org). They represent generic members of the GT-C
glycosyltransferase superfamily. Their predicted architecture is that
of large polytopic membrane proteins located in the ER or the plasma
membrane which display variations of a DXD motif in the ﬁrst lumi-
nal/extracellular loop region close to the membrane surface [54,55].
Like PMTs, most GT-Cs are inverting glycosyltransferases that utilize
lipid phosphate-activated sugar donors. Very recently, the ﬁrst three-
dimensional structure of a GT-C family member has been solved
[56]. The X-ray structure of oligosaccharyltransferase (OST) from
Campylobacter lari revealed that PglB features an N-terminal transmem-
brane region consisting of 13 TMDs, and a C-terminal periplasmic region.
Stt3, the eukaryotic homologue of bacterial OST, has been suggested to
be distantly related to PMTs (http://pfam.sanger.ac.uk/family/PMT;
A. Bateman personal observation), indicating that similarities in either
the architecture of the enzyme or the catalytic mechanism might be
present.
In eukaryotes, the PMT-family can be subdivided into three major
clades referred to as PMT1, PMT2 and PMT4 [57,58]. In S. cerevisiae,
two members of the PMT1 clade, three members of the PMT2 clade
and a single member of the PMT4 clade are present [51]. Redundancy
of PMT1 and PMT2 members is also observed in yeasts of the class
Saccharomycetes and in the opportunistic fungus Candida albicans
and might have evolved by genome/gene duplication as discussed
earlier [52]. In contrast, in other yeasts and in ﬁlamentous fungi
only a single member of each, PMT1, PMT2 and PMT4 is present
[11,59–64]. Interestingly, PMT1s are restricted to fungi, since in ani-
mals, only one member of each, the PMT2 and the PMT4 clade is
found [65,66]. For more information on PMTs and protein
O-mannosylation of fungi other than S. cerevisiae, of animals and of
bacteria we refer to previous reviews [52,53,58,59,67–69].
3.1. Structure-function relationship of PMT complexes
PMTs are ER membrane glycoproteins comprising seven trans-
membrane spanning domains (TMDs) [70]. The carboxyl-terminus
and the hydrophilic regions loop1 (between TMD1 and TMD2) and
loop5 (between TMD5 and TMD6) are located on the luminal side
of the ER membrane, whereas the amino-terminus, a hydrophobic re-
gion between TMD4 and TMD5, and the hydrophilic loop6 (between
TMD6 and TMD7) are facing the cytosol (Fig. 2A). PMTs form distinct
complexes among each other and complex formation is mandatory to
acquire full mannosyltransferase activity in yeasts and in mammals
[71–73]. In baker's yeast, PMT1s (Pmt1, Pmt5) form heterodimeric
complexes with PMT2s (Pmt2, Pmt3). Pmt1-Pmt2 complexes repre-
sent the predominant PMT1/PMT2 O-mannosyltransferase activity
in vitro and in vivo, although Pmt5-Pmt3 complexes are present
[72]. In the absence of the corresponding complex partner also
Pmt1-Pmt3 and Pmt5-Pmt2 interactions occur, suggesting a compen-
satory cooperation to maintain O-mannosyltransfer in the ER. In con-
trast to PMT1/PMT2 members, Pmt4 forms homodimeric complexes.
The same protein regions, especially an invariant arginine residue in
TMD2, are important for both hetero- and homomeric interactions
[72].
Yeast Pmt1-Pmt2 complexes have been characterized using a
photo-reactive mannosyl acceptor peptide [74]. The photo-probe
could be speciﬁcally cross-linked to the Pmt1-loop1 domain
(Fig. 2A). Mutations of a DE motif, which is highly conserved in the
loop1 region of PMTs from pro- and eukaryotes, hampered binding
of the photo-probe suggesting that this signature constitutes or is
part of the acceptor binding and/or the catalytic site. PMTs are
inverting glycosyltransferases that most likely employ a direct dis-
placement SN2-like mechanism involving an active-site aspartate or
glutamate side chain as an enzymatic base catalyst [55]. Very often,
at least three acidic amino acids are involved in this reaction mecha-
nism. However, since in Pmt1-Pmt2 complexes exchange of a singleacidic residue of the DE motif does not abolish enzymatic activity
[74] it is unlikely that one of those plays a role as direct catalyst.
More likely, they might be involved in the coordination of divalent
cations that position the catalytic base to interact with the substrate
and/or electrochemically stabilize the lipid phosphate leaving group
[55]. In line with this, it was shown that divalent Mg2+ cations stim-
ulate yeast PMT activity, even though chelators did not inhibit en-
zyme activity in vitro [75,76]. When the DE motif was replaced with
alanine residues mannosyltransferase activity of both, Pmt1-Pmt2
and Pmt4 complexes was completely lost. In contrast, single replace-
ment of either the aspartate or the glutamate residue abolished trans-
ferase activity of homodimeric Pmt4 complexes, although the same
mutations caused only a moderate reduction of enzymatic activity
of heterodimeric Pmt1-Pmt2 complexes [74]. These data suggest that
DE motifs of dimeric complexes could contribute to the catalytic site
(D77E78 in Pmt1 and D92E93 in Pmt2; D80E81 in Pmt4), thereby offer-
ing a possible explanation why physical interactions between two PMT
molecules are obligate for mannosyltransfer activity in baker's yeast.
However, in S. pombe, deletion of PMT2, but not of PMT1 results in
cell death, although they form a heteromeric complex and no other
PMT1/PMT2 members are conserved which could complement for
PMT2 activity [77]. There are several ways to explain these discrepan-
cies however, they are largely notional. Thus, to ultimately understand
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structural analysis of PMT complexes is mandatory for the future.
All eukaryotic PMTs contain three so called MIR motifs (mannosyl
transferase, inositol triphosphate- and ryanodine receptor) [78] within
the ER-luminal loop5 domain (Fig. 2A). In baker's yeast, this MIR do-
main is essential for enzymatic activity in vitro and in vivo [57], although
its deletion did not affect binding of a photo-reactive peptide substrate
[74]. Because bacterial and archaeal PMTs have a truncated loop5
lacking the MIR domain [52], it is highly unlikely that this region is
directly involved in catalysis but rather plays a yet unknown
ER-speciﬁc role. Interestingly, SDF2 (stromal cell-derived factor
2)-type proteins show signiﬁcant homology to the MIR domain of
the PMT-loop5 region. SDF2-type proteins are small hydrophilic ER
proteins that are conserved throughout the animal and plant king-
doms, but are absent in fungi [79,80]. They are ER stress-induced
components that interact with the molecular HSP40 co-chaperone
ERdj3 and in turn with the HSP70 chaperone BiP, and thus might
play a role in protein folding [80–82]. We recently solved the
3D-crystal structure of AtSDF2 [80,83]. It revealed a typical ß-trefoil
fold, which is found in a number of proteins that share little sequence
similarities, but among those chaperone interactors are frequently
found [84]. Based on the AtSDF2 structure, the loop5-MIR domain
of yeast PMTs has been modeled (A. Schott and S.S., unpublished
data) (Fig. 2B). Most interesting, alanine replacement of conserved
leucine residues that resulted in improper folding and aggregation
of AtSDF2 [80], also affected ScPmt1 activity [57] and folding of
Pmt1-loop5 (V. Girrbach and S.S., unpublished data), supporting
the signiﬁcance of the model. In analogy to SDF2-type proteins, theFig. 3. Occurrence of O-mannosylated proteins in S. cerevisiae. Mannoproteins have been ide
Mid2, and Fus1 that is involved in cell fusion [93,94]. In addition, many secretory proteins su
are highly O-mannosylated [136–138]. Typically, O-mannosyl glycans are clustered in Ser/T
speciﬁc proteins are O-mannosylated only in cases where they are not properly folded (for d
STR, Ser/Thr-rich region; GPIr, GPI remnant; cw, cell wall; cyt, cytosol; ex, extracellular spaPMT loop5-MIR domain might interact with ER chaperones in order
to retain an unfolded mannosylation competent state of substrate
proteins while they are entering the ER and/or to trigger
O-mannosylation of un-/misfolded proteins (see below). However,
both options have to be proven in the future. In contrast to the
Pmt1 domains in the ER lumen, little is known about the regions
that are oriented towards the cytosol, except that they are crucial
for mannosyltransferase activity [57].3.2. PMT protein substrates and substrate speciﬁcity
In the course of the last 20 years, many O-mannosylated proteins
have been identiﬁed including secretory proteins, proteins anchored
to the plasma membrane and the cell wall, or proteins located in
organelles of the secretory pathway [14,85–88] (Fig. 3). In most of
the cases, these proteins are substantially O-mannosylated and the
mannosyl chains are clustered in distinct Ser/Thr-rich regions
(Fig. 4A). An extreme example is the extensively O-mannosylated
cell surface ﬂocculin Flo11/Muc1 with 685 out of 1367 amino acids
being Ser/Thr residues [89]. A recent computational analysis rated
that in baker's yeast, about 45% of 594 signal peptide-containing pro-
teins (according to the SignalP server) have at least one region of 20
or more amino acids with a minimum Ser/Thr content of 40% [90].
Around 18% of the proteins with signal peptide were predicted to
contain 1-2 highly O-mannosylated Ser/Thr-rich regions with a
mean length of ~67 amino acids and a minimum of 25% O-glycosylated
residues.ntiﬁed including proteins anchored to the plasma membrane such as the sensor protein
ch as chitinase (Cts1) and proteins anchored to the cell wall (e.g., Aga2, Ccw5, Ccw12)
hr-rich regions, and affect stability or targeting of some of these proteins. In addition,
etails see 4.2). Mannose residues are depicted in green and N-glycans (Y) are indicated;
ce.
Fig. 4. PMT substrates are especially rich in Ser/Thr residues. The Ser/Thr content of proteins was calculated with a window size of 21 amino acids (A, B). (A) Clustering of
O-mannosyl glycans within Ser/Thr-rich regions of the cell wall proteins Aga2, Ccw12, Ccw5, and Sag1. Typically, the Ser/Thr content of regions bearing O-mannosyl glycans is
above 30%. Sequenced peptides (indicated as red lines) and experimentally veriﬁed O-mannosylation sites (marked in green) are shown according to [96,131,136,137]. Signal pep-
tide and Kex2 cleavage sites are denoted by ﬁlled and open arrows, respectively. Hydrophobic protein regions replaced by GPI anchors are illustrated as red boxes. (B) Comparison
of Ser/Thr content between non-substrate Exg1 [139], Pmt1-Pmt2 substrate Hsp150 [91], Pmt4 substrate Fus1 [93], and Pmt1-Pmt2, Pmt4 substrate Mid2 [94]. TMDs are depicted as
red boxes.
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numerous protein substrates (Fig. 4B) of which some have dozens
of O-mannosylation sites. Various S. cerevisiae proteins have been ex-
perimentally proven to be predominantly mannosylated by Pmt1-
Pmt2 (e.g., Kre9, Bar1, Pir2/Hsp150, and Aga2), yet others by Pmt4
(e.g., Kex2, Gas1, Axl2 and Fus1) [91–93]. Besides, there are examples
where Pmt1-Pmt2 and Pmt4 complexes act on the same protein but
mannosylate distinct regions, such as Cts1, Mid2, Mtl1, the WSC-
family members and Ccw5 [91,94–96]. Notably, Pmt1-Pmt2 complexes
act onboth, soluble andmembraneproteins,whereas Pmt4mannosylates
membrane-bound proteins, whereby the nature of themembrane anchor
is not relevant for recognition [97]. Moreover, various proteinswithmod-
erate Ser/Thr content have been described to be O-mannosylated by
Pmt1-Pmt2 only when they are not properly/efﬁciently folded (see
4.2.), whereas Pmt4-derived mannosylation of misfolded proteins has
not been observed yet. Even if mannosyltransferase activity is measured
in vitro, different speciﬁcities towards mannosyl acceptors are obvious.
In vitro, Pmt1-Pmt2 complexes transfer mannose from Dol-P-Man to Ser
and Thr residues of synthetic peptides ranging from tri- to oligomers
[46,75]. Derivatives of the pentapeptide YATAV turned out to be potent
in vitro acceptors with Km values in the micromolar range [49,98]. How-
ever, mannosyltransfer of Pmt4 to synthetic peptides could not be
detected [50]. We recently showed that Pmt4, but not Pmt1-Pmt2
activity can be measured in vitro using an assay that has been
established to detect PMT activity in mammals [74]. In this assay, a
recombinant GST-fusion protein of a mammalian PMT substrate is
serving as mannosyl acceptor [24], demonstrating that yeast Pmt4
and mammalian PMT complexes share substrate speciﬁcities, atthe very least in vitro. It is noteworthy, that O-mannosyl glycans
in mammals so far have only been found on membrane associated
proteins [99–101], suggesting that mammalian PMTs and yeast Pmt4
recognize similar features of their protein substrates also in vivo. The
basis of the different substrate speciﬁcities of PMT complexes is
not known yet, since in contrast to other types of glycosylation, sig-
nals for O-mannosylation of Ser and Thr residues appear to be not
just linear sequences of a protein's primary structure both in fungal
and in animal cells. Although various signature sequences had been
suggested, none proved itself true [46,102,103].
4. The role of protein O-mannosylation in baker's yeast
Protein O-mannosylation is an essential protein modiﬁcation in
fungi, animals, and humans [50,51,64,77,104,105]. In S. cerevisiae,
the analysis of viable pmtΔ mutants revealed that O-mannosyl gly-
cans are important for the stability, localization and/or function of
various secretory and membrane proteins and hence affect diverse
cellular processes such as cell polarity, cell wall integrity, mating
and ﬁlamentation [52,95,106]. The simultaneous knockout of particu-
lar combinations of PMTs (e.g., pmt1pmt2pmt4Δ) turned out to be le-
thal [50,51].
4.1. Protein O-mannosylation in an essential protein modiﬁcation
Why is O-mannosylation crucial for the survival of yeast cells?
The transcriptional response upon inhibition of O-mannosylation,
threw light on this question. In response to inhibition of all PMT
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stress signaling pathways turned out to be activated: i) the unfolded
protein response (UPR); ii) the cell wall integrity (CWI) pathway,
which provides a means to repair damages to the cell wall; and
iii) the STE vegetative growth (SVG) pathway, which promotes cell
wall integrity in parallel with CWI. Evidently, ER homeostasis and
cell wall integrity are primarily affected when O-mannosylation is
blocked [107].
Nascent secretory and membrane proteins synthesized at the
rough ER are translocated, potentially glycosylated and soon begin
to fold. Conditions that interfere with protein folding induce the accu-
mulation of misfolded proteins in the ER and thereby trigger a protec-
tive response termed the UPR and eventually, ER-associated protein
degradation (ERAD) [108,109]. The transcriptional program of the
UPR consists of genes involved in a wide range of cellular processes
comprising protein folding and glycosylation (including PMT1, PMT2,
PMT3, and PMT5), protein degradation, lipid biosynthesis and cell
wall construction [110]. In baker's yeast, under normal growth condi-
tions proteins receive O-mannosyl glycans while they are entering the
ER [45] (M. L. and S.S., unpublished data). Transcriptional proﬁling
showed that the UPR is activated when O-mannosylation is blocked
[107], most likely due to the accumulation of abnormal proteins
since O-mannosyl glycans affect solubility, maturation, and/or
targeting of various proteins [52]. Even in viable pmtΔ mutants
the UPR is constitutively induced under normal growth conditions
[111,112] (U. Schermer and S.S., unpublished data), and synthetic
lethal interactions between HAC1, the key transcription factor of
the UPR, and individual PMTs proved that the UPR is crucial for
survival of yeast cells when O-mannosylation is diminished
[107]. Since many proteins involved in cell wall biosynthesis and
structure are highly O-mannosylated (see 3.2.), decreased glyco-
sylation most likely results in aberrant cell wall mannoproteins
and, consequently, the CWI and the SVG pathways are activated
to buffer accruing cell wall defects.
The yeast cell wall is of vital importance. It is composed of ß-glu-
can (~50%), chitin (~2%) and mannoproteins (~48%) that are highly
N-glycosylated, O-mannosylated or both [86,113]. Mannoproteins
are structural and functional important cell wall components, and
their carbohydrate moieties regulate cell wall permeability and deter-
mine characteristics of individual proteins that are crucial for cell wall
biogenesis and structure [14,86]. Thus, glycosylation mutants fea-
ture cell wall-related phenotypes such as aberrant cell wall mor-
phologies and susceptibility towards cell wall disturbing agents
[47,51,114,115]. During vegetative growth and periods of environ-
mental stress the CWI MAP kinase pathway compensates for diverse
cell wall defects inter alia by enhancing the biosynthesis of certain
mannoproteins, chitin- and glucan-synthases [116]. In parallel, the
SVG pathway promotes cell wall integrity under vegetative growth
conditions especially when biosynthesis of mannoproteins is ham-
pered [117,118]. Inhibition of PMTs triggers the CWI pathway, and
in some pmtΔ mutants the CWI pathway is constitutively activated
[94,107] which goes along with an increased cell wall chitin content
[51]. The CWI pathway also results in the induction of the UPR [119].
However, in response to inhibition of O-mannosylation initiation of
the UPR occurs at least in part in a CWI pathway-independent man-
ner, since expression of many of the induced UPR target genes is ac-
tivated neither by a constitutive active CWI pathway nor in cell wall
mutants [107]. In addition to the CWI pathway, the SVG signaling
cascade is induced upon inhibition of PMTs, and its central transcrip-
tion factor Ste12 is crucial for vegetative cell growth when O-
mannosylation is low [107]. Ste12 is also a key regulator of the
MAPK pathways controlling mating of haploid yeast cells, and ﬁla-
mentous growth [120]. Interestingly, inhibition of O-mannosylation
resulted in an at least partially Ste-dependent repression of mat-
ing and ﬁlamentation genes, which appeared in strikingly re-
duced mating and invasive growth efﬁciencies of haploid yeastcells. ChIP analysis suggested that PMT inhibition is triggering the
displacement of the transcription factor Ste12 from mating and
ﬁlamentation genes towards targets of the SVG pathway [107]. In
this way, processes which involve extensive cell wall remodeling
are prevented, to protect cells from lysis when mannoprotein bio-
synthesis is impaired.
Both, the CWI and the SVG pathways boost inter alia the bio-
synthesis of cell wall mannoproteins to counteract cell wall defects
[121,122]. In addition, the UPR is activated to deal with the high
protein load of the ER. Like most ER chaperones and members of
the ERAD machinery, PMT1, PMT2, PMT3 and PMT5 are transcrip-
tionally induced during the UPR, further emphasizing their role
in ER homeostasis [110]. Absence of O-mannosylation however,
could provoke an inﬁnite loop, ﬁnally causing cell death due to
proteotoxic effects of accumulating aberrant mannoproteins in
the secretory pathway.4.2. Protein O-mannosylation and ER homeostasis
In addition to adding O-linked mannose to proteins entering the
ER, PMTs might have more speciﬁc functions during protein folding
in the ER. In recent years it turned out that various proteins are
O-mannosylated after translocation inside the ER by Pmt1-Pmt2
complexes when they are misfolded [123,124]. Especially when
ER-stress is triggered by tunicamycin (block of N-glycosylation),
O-mannosylation is signiﬁcantly increased and proteins that are nor-
mally not O-mannosylated receive O-mannosyl glycans [123]. Based
on these ﬁndings, it was proposed that prolonged ER residence allows
modiﬁcation of exposed O-mannosyl glycan acceptor sites within
misfolded proteins. To date, the fate of only a handful of artiﬁcial aber-
rant proteins has been analyzed that receive O-mannosyl glycans
whereas their wild-type counterparts do not [111,123–126]. Some of
them are more protected against degradation [123,125], while others
are degraded by the ERAD pathway [124,126]. Very recently, evidence
was presented that Pmt1-Pmt2 complexes have the capacity to inter-
actwith ER chaperones involved in oxidative protein folding (Pdi1 and
Ero1); the Hrd1 complex, which is functioning in ERAD; and the p24
protein complex, which participates in ER export of GPI-anchored pro-
teins [127]. Amodel has been suggestedwhere Pmt1-Pmt2 complexes
directly assist protein folding of the GPI-anchored protein Gas1.
In cases where ER export competent folding cannot be achieved,
interaction with Pmt1-Pmt2 might be extended. Consequently, O-
mannosylation increases and targets Gas1 for ERAD or post-ER
degradation [127]. For other examples of heterologously expressed
or misfolded proteins it has been reported that O-mannosylation by
PMTs increases their solubility and renders them less dependent on
the ER chaperone BiP/Kar2 [111,126,128]. As a consequence, aberrant
proteins bearing O-mannosyl glycans exit the ER for normal secretory
transport and are either degraded in the vacuole or secreted from the
cell [111]. When deletion of PMT2 was combined with mutants of
ERAD components, yeast cells exhibited enhanced UPR. Thus, it was
proposed that O-mannosylation might function as a fail-safe mecha-
nism by solubilizing aberrant proteins that deluge from the ERAD
pathway thereby reducing the load for ER chaperones [111]. While
analyzing the extracellular domain of the plasma membrane protein
Fus1 which is modiﬁed by Pmt4 [93], we observed that in the absence
of the membrane anchor Fus1 is entering the secretory pathway. The
majority of the protein however, is not mannosylated and accumu-
lates in the ER and a post-ER compartment [97]. Interestingly, a
fraction of the mutant protein is O-mannosylated by Pmt1-Pmt2 and
secreted into the medium, thereby supporting the model that
O-mannosyl glycans enhance the solubility of misfolded proteins and
facilitate their exit from the ER. Due to its complexity, to date the
physiological function of O-mannosylation for ER homeostasis still
needs to be deﬁned precisely.
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In recent years, an interdependence between protein
O-mannosylation and N-glycosylation became more and more obvious
in baker's yeast. Both types of glycosylation are initiated in the ER,
O-mannosylation by distinct PMT complexes and N-glycosylation by
the membrane protein complex OST [129]. Activity of both enzyme
complexes depends on the essential ER chaperone Rot1 [130], and
they can act on the same acceptor protein (e.g., [94–96,131]). It was
shown that PMTs and OST compete for acceptor protein substrates,
and that O-mannosylation can precede N-glycosylation, suggesting
that PMTs have the potential to alter the number of N-linked glycans
[96] (M.L. and S.S., unpublished data). The transcriptional proﬁles of
cells in which O-mannosylation [107] or N-glycosylation [110] was
selectively blocked, revealed that both defects result in activation of
the UPR, the CWI and the SVG pathways suggesting an overlapping
impact of O- and N-glycosylation on ER homeostasis and the yeast cell
wall. The idea that O- and N-linked glycans of cell wall mannoproteins
can at least partially compensate for each other in order to maintain
cell wall integrity, is further supported by the ﬁnding that transcription
of the Golgi mannosyltransferases OCH1, KTR2 and MNT4 that are in-
volved in the biosynthesis of the outer chain of N-linked high mannose
carbohydrates [21,115,132,133] is enhanced when O-mannosylation is
decreased [107]. As a quid pro quo, inhibition of N-glycosylation
increases transcription of PMTs and of the α1,2-mannosyltransferase
KTR1, which is involved in the extension of O-linked glycan chains in
the Golgi [133]. Further, epistatic miniarray proﬁles revealed strong
genetic interactions between N- and O-glycosylation machineries in
the early secretory pathway [134]. To tackle these interconnections
remains a challenging task for the future.Acknowledgements
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